Anti-FLT4 ADCC Enhanced Antibody (IMC-3C5) is an ADCC enhanced antibody produced by our Afuco™ platform. IMC-3C5 is a human IgG1 monoclonal antibody receptor antagonist designed to bind VEGFR3
and block the binding of VEGF-C and VEGF-D ligands to the receptor, used to treat solid tumors.
https://www.creativebiolabs.net/Anti-FLT4-ADCC-Enhanced-Antibody-IMC-3C5-20585.htm